NEMLUVIO
Generic: nemolizumab-ilto
Manufacturer: Galderma · Program: GPS (Galderma Patient Services) for NEMLUVIO
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or underinsured patients; co-pay assistance available for commercially insured patients
Residency
US resident or Puerto Rico resident
Program Information
Processing Time
2–4 weeks
Delivery Method
shipped to patient home address via specialty pharmacy
Application Method
Multiple
Indicated For
Atopic dermatitis, Prurigo nodolaris
About This Medication
# GPS (Galderma Patient Services) Patient Guide: How to Get NEMLUVIO (nemoluvio) at Low or No Cost NEMLUVIO (nemolizumab-ilto) is a prescription medication that helps relieve intense itching and skin symptoms for people with **moderate-to-severe atopic dermatitis** (eczema) or **prurigo nodularis**. The **GPS (Galderma Patient Services)** program from Galderma makes it easier to access NEMLUVIO at little or no cost if you're uninsured, underinsured, or need help with co-pays.[1][2][9] ## About NEMLUVIO **NEMLUVIO** is an interleukin-31 receptor alpha antagonist, which means it targets a specific protein that causes itching in conditions like atopic dermatitis and prurigo nodularis. It's approved for: - Adults and children **12 years and older** with moderate-to-severe atopic dermatitis not well-controlled by topical prescription therapies (used with topical corticosteroids and/or calcineurin inhibitors).[1][9] - Adults with **prurigo nodularis**.[2][9] Clinical data shows NEMLUVIO can rapidly reduce itch and improve sleep, sometimes as early as 48 hours after starting treatment.[10] It's given as a **prefilled pen** (30 g/0.49 mL) injected under the skin, typically every 4 weeks after the first few doses.[1] Always follow your doctor's instructions, and note important safety info: Avoid live vaccines during treatment, and stop use if you have a serious hypersensitivity reaction.[1] This guide focuses on the **GPS Patient Assistance Program**, which provides free or low-cost NEMLUVIO for eligible patients, plus co-pay help for those with commercial insurance.[5][6][8] ## Who Qualifies? GPS helps **uninsured or underinsured patients** who financially qualify and are prescribed NEMLUVIO. It's for U.S. residents (including Puerto Rico), typically **18 years or older**, though the drug is approved for ages 12+.[1][8] The program is **needs-based**, meaning income matters, but exact thresholds aren't publicly listed—call to check eligibility.[8] **Key eligibility groups:** - **Uninsured patients**: May get NEMLUVIO free if they meet income guidelines.[6][8] - **Underinsured patients**: Support for those with limited coverage.[1] - **Commercially insured**: Co-pay assistance to pay **as little as $0** out-of-pocket.[5][6] **Not eligible**: Medicare, Medicaid, or other government insurance patients (see FAQ for details). Programs like this often exclude federal insurance to comply with laws.[8] ## Income Eligibility Breakdown Specific income thresholds (like % of Federal Poverty Level) aren't detailed online, as they can change. The program is **needs-based**—Galderma reviews household income, size, and expenses.[8] Contact GPS at **(855) 636-5884** for your personalized check. Here's a general table based on similar programs (call to confirm for NEMLUVIO): | Household Size | Estimated Max Annual Income (300% FPL example)* | |----------------|------------------------------------------------| | 1 | ~$45,000 | | 2 | ~$61,000 | | 3 | ~$77,000 | | 4 | ~$93,000 | | +1 person | +$16,000 | *Examples only; actual limits vary. FPL = Federal Poverty Level. Provide proof like tax returns.[8] ## Insurance Requirements - **Uninsured/underinsured**: Primary focus—free medication if eligible.[6][8] - **Commercial insurance**: Co-pay card or assistance for **$0 copay** on NEMLUVIO prefilled pen.[5] - **Medicare/Medicaid**: Generally not eligible for free drug; explore other options like Extra Help.[8] Your doctor or GPS team verifies benefits. They handle prior authorizations and appeals.[2][4] ## Step-by-Step Application Process 1. **Get Prescribed**: Talk to your dermatologist about NEMLUVIO. They complete the **enrollment form**.[4][6] 2. **Enroll in GPS**: - Doctor faxes form to **844-636-5884** or submits online.[4][8] - Or you enroll at **https://galdermaps.iassist.com** or call **(855) 636-5884** (Mon-Fri, 8 AM-8 PM ET).[3][6][8] 3. **Submit Info**: Provide consent for credit check (for assistance), income proof if needed, and insurance details.[4] 4. **GPS Reviews**: They contact you (check voicemails), verify eligibility, and coordinate with specialty pharmacy.[4] 5. **Approval**: If approved, medication ships to your home.[1] **Multiple methods**: Online, phone, or doctor-led—choose what's easiest.[3] ## Timeline and Delivery Processing time varies (days to weeks), depending on insurance verification. GPS calls promptly; return calls quickly.[4] Once approved, NEMLUVIO ships **directly to your home** via specialty pharmacy—no pharmacy pickup needed.[1] First dose might be supervised; refills follow your prescription schedule. ## Alternatives if Denied - **Appeal**: Ask GPS for reasons and resubmit docs.[2] - **Co-pay program**: If commercially insured.[5] - **Other assistance**: Check NeedyMeds, RxAssist, or PAN Foundation for atopic dermatitis/prurigo nodularis funds.[7] - **Patient Access Network (PAN)** or state programs. - **Biosimilars**: None currently available.[ ] - Talk to your doctor about generics like topicals or other itch meds (e.g., dupilumab). ## Disclaimer This guide is for informational purposes based on publicly available data as of 2026. Eligibility, terms, and availability can change—**always verify with GPS at (855) 636-5884 or galdermaps.iassist.com**. Not medical advice; consult your healthcare provider. Galderma may discontinue the program anytime. Hypersensitivity to NEMLUVIO? Do not use.[1] Word count: ~950.
Program information last verified: March 30, 2026
Ready to apply for NEMLUVIO assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.